Sequence Group
Nicolas Soro is an accomplished executive with extensive experience in operations, regulatory affairs, and quality assurance within the medical device industry. Currently serving as the Founder and Managing Director of Sequence Group since January 2023, Nicolas previously held the position of Chief Operating Officer at Sensus Healthcare from December 2016 to January 2023, where responsibilities included managing daily operations of an organization generating over $45 million in annual revenue, leading research and development efforts, and ensuring regulatory compliance. Prior to Sensus Healthcare, Nicolas was the Director at DemeTech Corporation, where notable achievements included establishing the R&D division and transitioning to automated manufacturing processes. Nicolas holds an Emerging COO degree from Stanford University Graduate School of Business and a Bachelor's degree in Economics from Florida State University.
This person is not in any teams
This person is not in any offices
Sequence Group
With a team of highly experienced professionals and a deep understanding of the latest developments in medical device software, AI, and cutting-edge device technology, we are dedicated to helping our clients navigate the complex and ever-changing landscape of regulation and product design. Our goal is to help our clients bring innovative and effective medical devices to market as efficiently and effectively as possible, through strategic regulatory submissions and cutting-edge design and development solutions. We are committed to delivering exceptional service and results to all of our clients, and we look forward to the opportunity to partner with you on your next project.